Business Model & Traction
Multiple revenue streams ensuring sustainable growth from lab prototypes to global industrial scale.
Diverse Revenue Streams
Direct Reactor Sales
Core revenue from selling customised flow reactors to end users.
Custom Design & Engineering
Premium services for bespoke reactor configurations and process optimisation.
Consumables & Spare Parts
Recurring revenue from replacement components and maintenance supplies.
Training & Technical Support
Value-added services ensuring successful implementation and operation.
Pricing Logic
Per-reactor pricing with premium charges for customisation and specialised materials. Competitive positioning against expensive imported systems whilst maintaining healthy margins.
Unit Economics
High gross margins driven by digital design reuse, additive manufacturing efficiency, and minimal tooling costs compared to traditional fabrication methods.
Go-to-Market & Early Traction
We've generated strong early interest from pharmaceutical R&D teams and academic laboratories, with multiple organisations expressing interest in pilot programmes.
Direct B2B Sales
Targeted outreach to pharma and chemical R&D teams, supported by pilot projects and live demonstrations.
Pilot Deployments
Expand successful pilot projects into repeat orders and long-term partnerships.
Strategic Partnerships
Build relationships with CROs, CDMOs, and research institutions for sustained growth.
Validated Early Traction
Prototype Validation
Lab-scale prototype reactors successfully validated.
Throughput Gain
Reaction throughput improvement demonstrated.
Cost Reduction
Cost per reactor reduced versus traditional systems.
Our goal
"Targeting the launch of 2000 ml industrial-scale reactor by Q2 2026."
Invest or Partner With Us